Age years | Month | Die n | Survive n | Case fatality % | Risk ratio (95% CI) |
40–64 | |||||
Low comorbidity (Charlson 0) | November | 9 | 84 | 9.7 | 1.0 (0.5–2.0) |
December | 27 | 177 | 13.2 | 1.4 (0.9–2.2) | |
January | 16 | 150 | 9.6 | 1.0 (0.6–1.7) | |
February | 12 | 166 | 6.7 | 0.7 (0.4–1.3) | |
March | 11 | 196 | 5.3 | 0.6 (0.3–1.1) | |
April–October | 55 | 529 | 9.4 | Reference | |
Medium/high comorbidity (Charlson ≥1) | November | 10 | 64 | 13.5 | 0.8 (0.4–1.4) |
December | 18 | 112 | 13.9 | 0.8 (0.5–1.3) | |
January | 21 | 75 | 21.9 | 1.2 (0.8–1.9) | |
February | 22 | 102 | 17.7 | 1.0 (0.6–1.7) | |
March | 11 | 117 | 8.6 | 0.7 (0.4–1.3) | |
April–October | 81 | 381 | 17.5 | Reference | |
≥65 | |||||
Low comorbidity (Charlson 0) | November | 19 | 132 | 12.6 | 1.1 (0.7–1.8) |
December | 42 | 235 | 15.2 | 1.4 (0.9–1.9) | |
January | 34 | 144 | 19.1 | 1.7 (1.2–2.5)# | |
February | 32 | 178 | 15.2 | 1.4 (0.9–2.0) | |
March | 30 | 169 | 15.1 | 1.3 (0.9–2.0) | |
April–October | 68 | 540 | 11.2 | Reference | |
Medium/high comorbidity (Charlson ≥1) | November | 45 | 203 | 18.2 | 0.9 (0.7–1.2) |
December | 129 | 328 | 28.2 | 1.4 (1.1–1.6)# | |
January | 68 | 225 | 23.2 | 1.1 (0.9–1.4) | |
February | 84 | 227 | 27.0 | 1.3 (1.1–1.6)# | |
March | 69 | 238 | 22.5 | 1.1 (0.9–1.4) | |
April–October | Reference |
#: 95% confidence interval does not include 0 (significant at p<0.05).